Skip to main content

Major Depressive Disorders

0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Coordination Pharmaceuticals
1 program
case managementN/A1 trial
Active Trials
NCT01347138Completed57Est. Apr 2012
Sanofi
SanofiPARIS, France
1 program
amibegronPHASE_33 trials
Active Trials
NCT00855530Completed527Est. Jul 2007
NCT00825058Completed317Est. Oct 2004
NCT00825019Completed306Est. Dec 2004

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Sanofiamibegron
Sanofiamibegron
Sanofiamibegron
Coordination Pharmaceuticalscase management

Clinical Trials (4)

Total enrollment: 1,207 patients across 4 trials

NCT00855530Sanofiamibegron

Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder

Start: Sep 2005Est. completion: Jul 2007527 patients
Phase 3Completed
NCT00825058Sanofiamibegron

Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine

Start: Nov 2003Est. completion: Oct 2004317 patients
Phase 3Completed
NCT00825019Sanofiamibegron

Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine

Start: Sep 2003Est. completion: Dec 2004306 patients
Phase 3Completed
NCT01347138Coordination Pharmaceuticalscase management

Health Care Management for the Elderly in Community Through Screening

Start: May 2011Est. completion: Apr 201257 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.